摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-甲基-5-氧代-2,5-二氢-1H-吡唑-1-甲酰胺 | 89179-80-6

中文名称
3-甲基-5-氧代-2,5-二氢-1H-吡唑-1-甲酰胺
中文别名
——
英文名称
3-methyl-5-oxo-3-pyrazolin-1-carboxamide
英文别名
3-methyl-5-oxo-2,5-dihydro-pyrazole-1-carboxylic acid amide;3-Methyl-5-oxo-2,5-dihydro-pyrazol-1-carbonsaeure-amid;3-Methyl-5-oxo-2,5-dihydro-1H-pyrazole-1-carboxamide;5-methyl-3-oxo-1H-pyrazole-2-carboxamide
3-甲基-5-氧代-2,5-二氢-1H-吡唑-1-甲酰胺化学式
CAS
89179-80-6
化学式
C5H7N3O2
mdl
MFCD00666036
分子量
141.129
InChiKey
WLTWFLRTZOESNJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    228-230 °C
  • 沸点:
    268.3±23.0 °C(Predicted)
  • 密度:
    1.383±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    75.4
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933199090

SDS

SDS:86795afdb730c89570dbb27587c53eea
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Mechanistic investigation and DFT calculation of the new reaction between S-methylisothiosemicarbazide and methyl acetoacetate
    作者:Violeta Marković、Svetlana Marković、Ana Janićijević、Marko V. Rodić、Vukadin M. Leovac、Nina Todorović、Snežana Trifunović、Milan D. Joksović
    DOI:10.1007/s11224-013-0223-3
    日期:2013.12
    the synthesis and mechanistical aspects of formation of 3-methyl-5-oxo-3-pyrazolin-1-carboxamide (MOPC) starting from S-methylisothiosemicarbazide hydrogen iodide and methyl acetoacetate was performed. In the alkaline aqueous solution, the intermediate methyl acetoacetate S-methylisothiosemicarbazone undergoes substitution of CH3S− anion by hydroxide anion, cyclization, carbanion formation, and elimination
    对从 S-甲基异硫氨基脲碘化氢和乙酰乙酸甲酯开始形成 3-甲基-5-氧代-3-吡唑啉-1-甲酰胺 (MOPC) 的合成和机理方面进行了研究。在碱性水溶液中,中间体乙酰乙酸甲酯S-甲基异氨基硫脲经氢氧根阴离子取代CH3S-阴离子、环化、形成碳负离子和消除甲醇,从而产生相应的吡唑-5-酮衍生物的Na-烯醇盐。形成的烯醇盐质子化后得到的化合物的结构通过光谱技术和单晶X射线衍射分析确定。通过B3LYP功能研究了乙酰乙酸甲酯S-甲基异氨基硫脲转化为MOPC的机理,
  • Carriere, Annales de Chimie (Cachan, France), 1922, vol. <9> 17, p. 122
    作者:Carriere
    DOI:——
    日期:——
  • Backer; Meyer, Recueil des Travaux Chimiques des Pays-Bas, 1926, vol. 45, p. 94
    作者:Backer、Meyer
    DOI:——
    日期:——
  • Cobalt doped ZnS nanoparticles as a recyclable catalyst for solvent-free synthesis of heterocyclic privileged medicinal scaffolds under infrared irradiation
    作者:Anshu Dandia、Vijay Parewa、Shyam L. Gupta、Kuldeep S. Rathore
    DOI:10.1016/j.molcata.2013.02.010
    日期:2013.7
    This paper reports preparation and characterization of cobalt doped ZnS NPs and their catalytic application in the synthesis of heterocyclic privileged medicinal scaffolds involving pyrazolones (with excellent regioselectivity) and 1,3-oxathiolan-5-one frameworks under infrared irradiation. Nanoparticles have been prepared at room temperature by a wet chemical method. The heterogeneous catalysts were fully characterized by XRD, TEM, EDAX, ICP-AES and UV/Vis. Under infrared radiation (IR), the catalytic activity of Co doped ZnS NPs was about 40-fold higher under IR as compared to the conventional method. Nanocatalyst plays a dual role of catalyst as well as susceptor, and enhances the overall capacity to absorb IR in the reaction mixture. Doping by Co promotes the activity and selectivity of ZnS NPs as indicated by their high TOF value, providing the products with good to excellent yields. The surface acidity of NPs was measured by FTIR spectra of chemisorbed pyridine. The present method does not involve any hazardous organic solvent or catalyst. The introduction of nanocatalyst in an IR system offers promising features for the reaction response such as the shorter reaction time, simple work-up procedure, and purification of products by non-chromatographic methods. The catalyst was reused up to four runs without an appreciable loss of catalytic activity. (C) 2013 Elsevier B.V. All rights reserved.
  • De, Journal of the Indian Chemical Society, 1926, vol. 3, p. 35
    作者:De
    DOI:——
    日期:——
查看更多

同类化合物

(4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] 香豆素-6-羧酸 锌离子载体IV 钐(III) 离子载体 II 苯,(2,2-二氟乙烯基)- 聚二硫二噻唑烷 缩胆囊肽9 甲酰乙内脲 甲巯咪唑 甲基羟甲基油基噁唑啉 甲基5-羟基-3,5-二甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-氰基-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基5-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-5-氧代-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4,5-二氮杂螺[2.4]庚-5-烯-6-羧酸酯 甲基4,5-二氢-5-乙基-1H-吡唑-1-羧酸酯 甲基(E)-3-[6-[1-羟基-1-(4-甲基苯基)-3-(1-吡咯烷基)丙基]-2-吡啶基]丙烯酰酸酯 甲基(5-氧代-4,5-二氢-1,2-恶唑-3-基)乙酸酯 环戊二烯并[d]咪唑-2,5(1H,3H)-二硫酮 溶剂黄93 溴化1-十六烷基-3-甲基咪唑 溴化1-十二烷基-2,3-二甲基咪唑 泰比培南酯中间体 泰比培南酯中间体 氨基甲硫酸,[2-[[(2-羰基-1-咪唑烷基)硫代甲基]氨基]乙基]-,O-甲基酯 异噻唑,4,5-二氯-2,5-二氢-2-辛基- 希诺米啉 四氟硼酸二氢1,3-二(叔-丁基)-4,5--1H-咪唑正离子 四唑硝基紫 噻唑丁炎酮 噻唑,4,5-二氢-4-(1-甲基乙基)-,(S)- 噁唑,4,5-二氢-4,4-二甲基-2-(5-甲基-2-呋喃基)- 噁唑,2-庚基-4,5-二氢- 咪唑烷基脲 吡嗪,2,3-二氢-5,6-二甲基-2-丙基- 叔-丁基3-羟基-1,4,6,7-四氢吡唑并[4,3-c]吡啶-5-羧酸酯 双吡唑啉酮 双[(S)-4-异丙基-4,5-二氢噁唑-2-基]甲烷 双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)甲烷 利美尼啶D4 利美尼啶 假硫代乙内酰脲 依达拉奉杂质DO 依达拉奉杂质 依达拉奉三聚体 依达拉奉 仲班酸